Protecting the World through InnovationHPOUSA.comAt HPO, our Mission is to “Protect the World through Innovation.” HPO was founded in 2006 through work focused on protecting the human retina from High Energy Visible Light (HEVL). Our first application opportunities were in ophthalmics where we have now Licensed our Intellectual Property (IP) and Technology to some of the largest companies in the world. HPO IP and Technology now offer protection for hundreds of millions of eyes around the world from the dangers of HEVL.Since inception, nearly 100 patent applications have been filed and more than half that number have been issued. In 2018, HPO stands as the leader in Intellectual Property and the Development of Technology for that purpose. With a Vision “To Standardize Protection from HEVL in every application that can protect the human retina and skin,"​ we have pushed beyond the boundaries of ophthalmic lenses. HPO is activity exploring, with the largest companies worldwide, new protection opportunities that can continue to advance protection from HEVL to the human retina and skin cells. Today, HPO is in joint development projects with world leaders within their prospective fields to create innovative new chemistry for protection from HEVL.HPO, dedicated to its Mission, continues to intensify its resources towards new innovations that protect and can be applied globally. We encourage you to contact HPO to discuss and discover new paths for your company.

Developed and Executed worldwide Commercialization Plan for world’s first electronic focusing eyewear. Raising $45,000,000 in venture capital

Revenue & Profit Growth: Developed strategic growth plan increasing revenue from $500,000,000 to $12,400,000,000 with over $1.2 Billion in profit created over 8 years.Share Growth: Market share from 12th to 1st, penetration from 10% to 76%. Growth in consumer base by 23x in 8 years. Cost & Scale Management: $60,000,000 operating budget. Built scalable platforms that produced over 400% improvement in scale costs.Department consistently rated as "Best Place to Work" in company annual reviews.

Built sales & marketing platform for heath care start-up that was sold to J&J for $164 million in 1998. Supported in raising $3 million and Angel Funding. Created national launch strategy for new J&J sales organization, coordinating market penetration plan and staffing. Boosting market share position from 15th to 3rd in four years.